ARGX Q4 2023 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena

ARGXargenx SE

$46B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$758M+150.1% YoY

Gross Profit

$184M24.3% margin

Operating Income

-$219M-28.9% margin

Net Income

-$156M-20.5% margin

EPS (Diluted)

$-2.95

QoQ Revenue Growth

+129.7%

Cash Flow

Operating Cash Flow

-$135M

Free Cash Flow

-$135M

Stock-Based Comp.

$131M

Balance Sheet

Total Assets

$4.5B

Total Liabilities

$445M

Stockholders' Equity

$4.1B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$758M	$303M	+150.1%
Gross Profit	$184M	-$78M	+337.0%
Operating Income	-$219M	-$302M	+27.3%
Net Income	-$156M	-$256M	+39.1%

Geographic Segments

United States

$606M88%

EMEA

$50M7%

Japan

$33M5%